Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
12 NC counties are under alert, including Johnston County.
Just In
Decision 2024: North Carolina judge won't prevent use of university digital IDs for voting
Just In
Judge shot & killed: Authorities say local Kentucky sheriff fatally shot a judge in his chambers
Program
After baseball on FOX 50: Mark Robinson under pressure for alleged lewd comments. Whatâs at stake as he vows to stay in the race
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vistagen Therapeutics Inc
(NQ:
VTGN
)
3.000
+0.010 (+0.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
175,599
Open
3.060
Bid (Size)
2.990 (4)
Ask (Size)
3.200 (5)
Prev. Close
2.990
Today's Range
2.990 - 3.080
52wk Range
2.450 - 5.860
Shares Outstanding
9,362,444
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases Q1 2025 Financial, Corporate Report
August 14, 2024
Via
Investor Brand Network
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025
August 13, 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
Via
InvestorPlace
Performance
YTD
-41.75%
-41.75%
1 Month
-16.43%
-16.43%
3 Month
-6.83%
-6.83%
6 Month
-28.83%
-28.83%
1 Year
-42.20%
-42.20%
More News
Read More
Vistagen Reports Fiscal Year 2025 First Quarter Financial Results and Corporate Update
August 13, 2024
From
Vistagen
Via
Business Wire
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules Release of Q1 2025 Results, Conference Call
August 06, 2024
Via
Investor Brand Network
Vistagen to Report Fiscal Year 2025 First Quarter Results and Host Corporate Update Conference Call on August 13, 2024
August 06, 2024
From
Vistagen
Via
Business Wire
3 Stocks Under $15 That Could Make You a Millionaire
July 26, 2024
Via
InvestorPlace
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Awarded New Patents from Four Countries to Broaden Global PH80 IP Portfolio
July 09, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine
July 09, 2024
From
Vistagen
Via
Business Wire
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Receives Mental Health America’s Highest Honor
June 27, 2024
Via
Investor Brand Network
Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year
June 27, 2024
From
Vistagen
Via
Business Wire
TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases FY 2024 Financial Report, Corporate Update
June 12, 2024
Via
Investor Brand Network
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024
June 12, 2024
Via
InvestorPlace
Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
June 11, 2024
From
Vistagen
Via
Business Wire
BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules FY 2024 Financial Results Report, Conference Call
June 07, 2024
Via
Investor Brand Network
Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024
June 07, 2024
From
Vistagen
Via
Business Wire
TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) CEO to Present at Jefferies Global Healthcare Conference
May 29, 2024
Via
Investor Brand Network
Vistagen to Present at the Jefferies Global Healthcare Conference
May 29, 2024
From
Vistagen
Via
Business Wire
BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Present Posters at Upcoming ASCP Conference
May 23, 2024
Via
Investor Brand Network
Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology (ASCP) Conference
May 23, 2024
From
Vistagen
Via
Business Wire
3 Must-Have Penny Stocks to Boost Your 2024 Portfolio
May 14, 2024
Via
InvestorPlace
Meme Stock Rebound: 3 Reddit Favorites Primed for a Resurgence
May 13, 2024
Via
InvestorPlace
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Present at Upcoming RBC Capital Markets Global Healthcare Conference
May 07, 2024
Via
Investor Brand Network
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 07, 2024
From
Vistagen
Via
Business Wire
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Reports Positive PH15 Data from Pilot Study Showing Psychomotor Impairment Improvement
April 25, 2024
Via
Investor Brand Network
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
April 25, 2024
From
Vistagen
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.